Efficacy of Periodontal Treatment on Glycaemic Control in Diabetic Patients

Status

Completed

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT02563457

Acronym

DIAPERIO

Enrollment

Registered

2015-09-30

Start date

2009-02-28

Completion date

2015-08-31

Last updated

2025-12-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes

Keywords

diabetic patients, periodontal treatment, glycaemic control

Brief summary

This study will assess the efficacy of periodontal treatment in diabetic patient. Patients will be randomized in the periodontal group or in the control group. The control group will received a periodontal treatment after the study.

Interventions

OTHERperiodontal manual treatment

periodontal manual treatment

OTHERno periodontal manual treatment

blood sampling

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

TREATMENT

Masking

NONE

Eligibility

Sex/Gender

ALL

Healthy volunteers

Inclusion criteria

* patient suffering from a periodontitis * patient with : 7,0% \< Hemoglobin A1c \< 9,5%

Exclusion criteria

* If an hospitalization is planned within the next 4 months * Patient suffering from chronic infectious pathology (HIV, hepatitis C virus, hepatitis B virus, mononucleosis) * Renal insufficiency * Contra indication for amoxicilline or clindamycin * Antithrombotic treatment * Liver disease

Design outcomes

Primary

Measure	Time frame	Description
Hemoglobin A1c blood level	3 months	efficacy of periodontal treatment on hemoglobin A1c

Other

Measure	Time frame	Description
fructosamine blood level	3 weeks	Compare the fructosamine content in blood between the 2 groups
Quality of life	3 months	Compare the quality of life between the 2 groups using the 36-Item Short Form Health Survey (SF36)

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026